Stock market week-in-review for 5 large GI companies — Oct. 2-6

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 2 to Oct. 6, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $204.89 on Oct. 2
Peaked: $213.88 on Oct. 3
Closed: $206.68 Oct. 6
Percent change between Oct. 2 and Oct. 6: 0.87 percent

2. Exact Sciences Corp.

Opened: $46.76 on Oct. 2
Peaked: $50.46 on Oct. 3
Closed: $48.63 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 3.99 percent

3. Johnson & Johnson

Opened: $130.25 on Oct. 2
Peaked: $133.26 on Oct. 5
Closed: $133.17 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 2.24 percent

4. Synergy Pharmaceuticals

Opened: $2.90 on Oct. 2
Peaked: $3.53 on Oct. 5
Closed: $3.46 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 19.31 percent

5. Valeant Pharmaceuticals

Opened: $14.33 on Oct. 2
Peaked: $14.74 on Oct. 3
Closed: $14.46 on Oct. 6
Percent change between Oct. 2 and Oct. 6: 0.90 percent

More articles on gastroenterology: 
Medicare saved $8.8M by shifting colonoscopies to Tennessee ASCs: 3 quick facts
GI leader to know: Dr. Rand Compton of Centers for Gastroenterology
Takeda donates $100k to local nonprofits — 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.